November 24, 2016 - By kentuckypostne · 0 Comments
Mckesson Corp (NYSE:MCK) institutional sentiment increased to 1.06 in Q2 2016. Its up 0.23, from 0.83 in 2016Q1. The ratio is more positive, as 357 institutional investors increased and started new positions, while 432 decreased and sold their positions in Mckesson Corp. The institutional investors in our partner’s database now possess: 186.66 million shares, down from 200.54 million shares in 2016Q1. Also, the number of institutional investors holding Mckesson Corp in their top 10 positions increased from 13 to 18 for an increase of 5. Sold All: 79 Reduced: 353 Increased: 269 New Position: 88.
McKesson Corporation is engaged in delivering pharmaceuticals, medical supplies and healthcare information technology. The company has a market cap of $31.93 billion. The Firm operates through two divisions: McKesson Distribution Solutions and Technology Solutions. It has a 15.86 P/E ratio. The McKesson Distribution Solutions segment distributes drugs and equipment, and health and beauty care products across North America and internationally.
The stock decreased 0.04% or $0.06 on November 23, hitting $141.27. About 2.12M shares traded hands. McKesson Corporation (NYSE:MCK) has declined 20.75% since April 22, 2016 and is downtrending. It has underperformed by 26.16% the S&P500.
Analysts await McKesson Corporation (NYSE:MCK) to report earnings on January, 25. They expect $2.96 earnings per share, down 6.92% or $0.22 from last year’s $3.18 per share. MCK’s profit will be $669.02M for 11.93 P/E if the $2.96 EPS becomes a reality. After $2.94 actual earnings per share reported by McKesson Corporation for the previous quarter, Wall Street now forecasts 0.68% EPS growth.
According to Zacks Investment Research, “McKesson Corporation, the world’s largest health care service and technology company, delivers unique supply and information management solutions that reduce costs and improve quality for its health care customers. The Company is organized under two operating segments: Health Care Supply Management and Health Care Information Technology.”
Southpoint Capital Advisors Lp holds 11.48% of its portfolio in McKesson Corporation for 1.15 million shares. Kdi Capital Partners Llc owns 140,995 shares or 8.34% of their US portfolio. Moreover, North Run Capital Lp has 7.08% invested in the company for 230,000 shares. The California-based Crescent Park Management L.P. has invested 5.94% in the stock. Meritage Group Lp, a California-based fund reported 1.11 million shares.#img1#
Insider Transactions: Since January 1, 0001, the stock had 1 buy, and 7 sales for $37.72 million net activity.
Ratings analysis reveals 41% of McKesson Corporation’s analysts are positive. Out of 17 Wall Street analysts rating McKesson Corporation, 7 give it “Buy”, 1 “Sell” rating, while 9 recommend “Hold”. The lowest target is $147 while the high is $275. The stock’s average target of $203.25 is 43.87% above today’s ($141.27) share price. MCK was included in 42 notes of analysts from July 31, 2015. Goldman Sachs downgraded McKesson Corporation (NYSE:MCK) rating on Friday, September 16. Goldman Sachs has “Neutral” rating and $189 price target. Mizuho maintained McKesson Corporation (NYSE:MCK) rating on Monday, September 21. Mizuho has “Buy” rating and $275 price target. Deutsche Bank downgraded the stock to “Hold” rating in Friday, October 28 report. Deutsche Bank maintained McKesson Corporation (NYSE:MCK) on Tuesday, January 12 with “Buy” rating. On Wednesday, November 23 the stock rating was downgraded by Credit Suisse to “Underperform”. The stock of McKesson Corporation (NYSE:MCK) earned “Neutral” rating by Mizuho on Thursday, August 11. The stock of McKesson Corporation (NYSE:MCK) earned “Outperform” rating by FBR Capital on Thursday, July 30. The firm has “Hold” rating given on Friday, November 11 by Standpoint Research. FBR Capital maintained the shares of MCK in a report on Tuesday, January 12 with “Outperform” rating. S&P Research maintained McKesson Corporation (NYSE:MCK) rating on Friday, July 31. S&P Research has “Buy” rating and $268 price target.
McKesson Corporation (McKesson), incorporated on July 7, 1994, is a pharmaceutical distribution services and information technology company. The Firm delivers an offering of pharmaceuticals and medical supplies. The Firm operates through two divisions: McKesson Distribution Solutions and McKesson Technology Solutions.
Another recent and important McKesson Corporation (NYSE:MCK) news was published by Seekingalpha.com which published an article titled: “Why McKesson Corporation Shares Fell 23% In A Day” on October 30, 2016.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.